Trial comparisons11

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

1 to 11 of 11

Comparison	Source
TDF/FTC vs Placebo: Grade 3 or Higher Phosphorous Toxicity	Trial comparisons
TDF/FTC vs Placebo: Incidence of Confirmed Syphilis During Follow-Up	Trial comparisons
TDF/FTC vs Placebo: Grade 1 or Higher Creatinine Toxicity	Trial comparisons
TDF/FTC vs Placebo: Hepatitis Flares Among Hepatitis B Virus (HBV) Infected Persons During and After Chemoprophylaxis	Trial comparisons
TDF/FTC vs Placebo: HIV Seroconversion	Trial comparisons
TDF/FTC vs Placebo: Incidence of HSV-2 During the Follow-up Period	Trial comparisons
TDF/FTC vs Placebo: Condomless Receptive Anal Intercourse in the Previous 12 Weeks With Any Partners Regardless of Status.	Trial comparisons
TDF/FTC vs Placebo: Diagnosis of Gonorrhea During the Follow-up Period	Trial comparisons
TDF/FTC vs Placebo: Grade 2, 3, or 4 Laboratory Adverse Events	Trial comparisons
TDF/FTC vs Placebo: Grade 2, 3, or 4 Clinical Adverse Events	Trial comparisons
TDF/FTC vs Placebo: serious adverse events	Trial comparisons

trials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00458393/comparisons